NFKB1 and neoplasm: However, when activated by various carcinogens, tumor promoters, or proinflammatory agents, ubiquitination and degradation of IκBα promoted NF-κB (p65 subunit) release from the cytoplasm to the nucleus (Alok and Bharat, 2002).